Zimbabwe has turned down a significant US health deal valued at $367m (£272m) spanning five years because of Washington's insistence on sensitive data.
This move became public following a government memo from December was leaked, which showed President Emmerson Mnangagwa felt the arrangement was "lopsided".
A government representative later clarified that the United States was demanding access to biological samples for scientific study and profit while was not willing to share the resulting advantages from any future treatments.
"We will now turn to the challenging and unfortunate process of ending our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had provided more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for continued negotiations to reach a agreement agreeable to both sides so the country's vital HIV programme can be sustained.
Broader Implications
This development comes after a comparable situation in neighbouring Kenya, where a court halted a similar deal with the US following legal challenges were raised about the safety of citizens' medical information.
Since returning to the presidency last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
USAID had administered assistance for the American government, but Trump argued its expenditure was "inefficient" and his administration was seeking government-to-government agreements to boost transparency and accountability.
Based on reports, 16 African countries have so far signed these new agreements, representing over $18.3bn of fresh investment.
Details of the Rejected Deal
The money for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration could have provided significant advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving HIV treatment via US-supported initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana said the arrangement was "unfair".
"Our nation was requested to share its genetic material and health information over an extended period, without any equivalent assurance of access to any scientific breakthroughs – such as new medicines or tests – that could be developed from that provided information," his statement read.
"In essence, our country would provide the raw materials for scientific discovery without any certainty that the end products would be accessible to our citizens if a future health crisis emerge."
National Interest and International Frameworks
He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were upending systems previously established via the international health agency.
The spokesperson cited its Pandemic Benefit-Sharing framework created to manage future global health emergencies.
"This system is designed to ensure that when a nation contributes its data, the benefits – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to create them."
These objections over the US deal "are not meant as opposition to America," Mangwana stressed.
"We are open to ongoing discussions with our US partners on how future co-operation might be arranged in a way that respects the sovereignty and interests of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the official position, but recommended that negotiations should continue considering much of the nation's Aids initiatives were funded by foreign aid.
"Where specific concerns exist, such as those involving data governance or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," the group commented.
The situation emphasises the ongoing challenges between accepting much-needed foreign assistance and protecting a country's data in an ever more data-driven world.